Literature DB >> 23509132

Is transdermal menopausal hormone therapy a safer option than oral therapy?

Bette Liu.   

Abstract

Mesh：

Year:  2013        PMID： 23509132      PMCID： PMC3626805          DOI： 10.1503/cmaj.130004

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.

Authors:  Adrianne Faber; Marcel L Bouvy; Linda Loskamp; Paul B van de Berg; Toine C G Egberts; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

2.  Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Authors:  Marianne Canonico; Emmanuel Oger; Geneviève Plu-Bureau; Jacqueline Conard; Guy Meyer; Hervé Lévesque; Nathalie Trillot; Marie-Thérèse Barrellier; Denis Wahl; Joseph Emmerich; Pierre-Yves Scarabin
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

3.  Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.

Authors:  Emily Banks; Valerie Beral; Gillian Reeves; Angela Balkwill; Isobel Barnes
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

4.  Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort.

Authors:  Antoine Racine; Anne Bijon; Agnès Fournier; Sylvie Mesrine; Françoise Clavel-Chapelon; Franck Carbonnel; Marie-Christine Boutron-Ruault
Journal:  CMAJ       Date:  2013-03-18       Impact factor: 8.262

5.  Breast cancer and hormone-replacement therapy in the Million Women Study.

Authors:  Valerie Beral
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

6.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

Authors:  Adam L Hersh; Marcia L Stefanick; Randall S Stafford
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

7.  Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Authors:  Emily Banks; Karen Canfell
Journal:  Am J Epidemiol       Date:  2009-05-25       Impact factor: 4.897

8.  Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.

Authors:  S Sweetland; V Beral; A Balkwill; B Liu; V S Benson; M Canonico; J Green; G K Reeves
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

9.  Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.

Authors:  Bette Liu; Valerie Beral; Angela Balkwill; Jane Green; Siân Sweetland; Gillian Reeves
Journal:  BMJ       Date:  2008-07-10
  9 in total
  1 in total

1.  Menopausal hormone therapy and risk of biliary tract cancers.

Authors:  Sarah S Jackson; Ruth M Pfeiffer; Chiara Gabbi; Lesley Anderson; Shahinaz M Gadalla; Jill Koshiol
Journal:  Hepatology       Date:  2022-02       Impact factor: 17.298
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.